SEC Form 4 · accession 0000899243-18-023650
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garrison J. Hasara
Officer — CFO and Treasurer
Period of report
Aug 30, 2018
Accepted (ET)
Aug 31, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 30, 2018 | S | 100,000 | $0.27 | D | 3,959,044 | D |
Table II — derivative securities
No Table II lines on this filing.